Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients.
作者信息
Cassone Antonio, Iacoviello Licia, Cauda Roberto
机构信息
Polo d'Innovazione della Genomica, Genetica e Biologia, University of Siena.
Department of Epidemiology & Prevention, IRCCS Neuromed, Pozzilli (IS), Italy.
出版信息
Future Microbiol. 2020 Oct;15:1523-1526. doi: 10.2217/fmb-2020-0247. Epub 2020 Nov 18.
Abstract
摘要
相似文献
1
Knowing more about chloroquine/hydroxycloroquine in COVID-19 patients.进一步了解新冠病毒肺炎患者使用氯喹/羟基氯喹的情况。
Future Microbiol. 2020 Oct;15:1523-1526. doi: 10.2217/fmb-2020-0247. Epub 2020 Nov 18.
2
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.氯喹或羟氯喹预防和治疗 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 12;2(2):CD013587. doi: 10.1002/14651858.CD013587.pub2.
3
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story.氯喹和羟氯喹治疗 COVID-19：一个永无止境的故事。
Appl Microbiol Biotechnol. 2021 Feb;105(4):1333-1343. doi: 10.1007/s00253-021-11094-4. Epub 2021 Jan 30.
4
Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.氯喹和羟氯喹在治疗 COVID-19 中的应用进展。
Postgrad Med. 2020 Sep;132(7):604-613. doi: 10.1080/00325481.2020.1778982. Epub 2020 Jun 21.
5
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).氯喹和羟氯喹在冠状病毒病-19（COVID-19）中的预防作用的系统评价。
Int J Rheum Dis. 2020 May;23(5):613-619. doi: 10.1111/1756-185X.13842. Epub 2020 Apr 27.
6
COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.新型冠状病毒肺炎疫情：氯喹和羟氯喹潜在作用的叙事性综述。
Pain Physician. 2020 Aug;23(4S):S351-S366.
7
Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.氯喹和羟氯喹用于预防和治疗2019冠状病毒病：新希望与旧有的心血管问题
Kardiol Pol. 2020 Aug 25;78(7-8):811-817. doi: 10.33963/KP.15511. Epub 2020 Jul 14.
8
The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?4-氨基喹啉类药物（氯喹/羟氯喹）抗 SARS-CoV-2 感染（COVID-19）的可能作用机制：铁稳态的作用？
Pharmacol Res. 2020 Aug;158:104904. doi: 10.1016/j.phrs.2020.104904. Epub 2020 May 13.
9
Hydroxychloroquine/Chloroquine as Therapeutics for COVID-19: Truth under the Mystery.羟氯喹啉/氯喹啉作为COVID-19的治疗方法：谜团背后的真相。
Int J Biol Sci. 2021 Apr 10;17(6):1538-1546. doi: 10.7150/ijbs.59547. eCollection 2021.
10
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.（羟）氯喹对抗 COVID-19 无效的原因：细胞生物学的见解。
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.
引用本文的文献
1
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering.通过分层聚类解析羟氯喹治疗与 COVID-19 住院患者死亡率的关联。
J Healthc Eng. 2021 Jun 25;2021:5556207. doi: 10.1155/2021/5556207. eCollection 2021.
本文引用的文献
1
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的疗效。
N Engl J Med. 2020 Nov 19;383(21):2030-2040. doi: 10.1056/NEJMoa2022926. Epub 2020 Oct 8.
2
Azithromycin in viral infections.阿奇霉素治疗病毒感染。
Rev Med Virol. 2021 Mar;31(2):e2163. doi: 10.1002/rmv.2163. Epub 2020 Sep 23.
3
Population Pharmacokinetics of Hydroxychloroquine in COVID-19 Patients: Implications for Dose Optimization.羟氯喹在新冠肺炎患者中的群体药代动力学：对剂量优化的启示。
Eur J Drug Metab Pharmacokinet. 2020 Dec;45(6):703-713. doi: 10.1007/s13318-020-00648-y.
4
Evaluation of current medical approaches for COVID-19: a systematic review and meta-analysis.评估当前针对 COVID-19 的医学方法：系统评价和荟萃分析。
BMJ Support Palliat Care. 2021 Mar;11(1):45-52. doi: 10.1136/bmjspcare-2020-002554. Epub 2020 Sep 21.
5
Characteristics of COVID-19 clinical trials registered with ClinicalTrials.gov: cross-sectional analysis.在ClinicalTrials.gov上注册的COVID-19临床试验的特征：横断面分析。
BMJ Open. 2020 Sep 17;10(9):e041276. doi: 10.1136/bmjopen-2020-041276.
6
Chloroquine against malaria, cancers and viral diseases.氯喹用于治疗疟疾、癌症和病毒性疾病。
Drug Discov Today. 2020 Sep 16;25(11):2012-22. doi: 10.1016/j.drudis.2020.09.010.
7
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).干预治疗 COVID-19：一项具有荟萃分析和试验序贯分析的实时系统评价（LIVING 项目）。
PLoS Med. 2020 Sep 17;17(9):e1003293. doi: 10.1371/journal.pmed.1003293. eCollection 2020 Sep.
8
Pathophysiology and treatment strategies for COVID-19.COVID-19 的病理生理学和治疗策略。
J Transl Med. 2020 Sep 15;18(1):353. doi: 10.1186/s12967-020-02520-8.
9
No benefit of hydroxychloroquine in COVID-19: Results of Systematic Review and Meta-Analysis of Randomized Controlled Trials".羟氯喹在 COVID-19 中无益：随机对照试验的系统评价和荟萃分析结果。
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1673-1680. doi: 10.1016/j.dsx.2020.08.033. Epub 2020 Sep 1.
10
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study.羟氯喹在住院 COVID-19 患者中的应用与降低死亡率相关：来自意大利 CORIST 观察性多中心研究的结果。
Eur J Intern Med. 2020 Dec;82:38-47. doi: 10.1016/j.ejim.2020.08.019. Epub 2020 Aug 25.
Zotero 插件